Tag: Prescription Drugs
Comparative Effectiveness of Treatments Explored in T2DM
Greatest drop in HbA1c for insulin, specific glucagon-like peptide-1 receptor agonist added to metformin
COVID-19 Drug Remdesivir Could Cost Up to $3,120 Per Patient
In the U.S., government programs, additional Gilead assistance should mean all patients have access to the drug
Colchicine May Improve Time to Clinical Deterioration in COVID-19
Significant improvement seen in time to clinical deterioration for hospitalized patients with COVID-19
Triple Inhaled Therapy Aids in Moderate-to-Very Severe COPD
Benefit seen for twice-daily triple inhaled therapy with glucocorticoid, glycopyrrolate, formoterol
Inhibition of Sclerostin May Increase Cardiovascular Risk
SOST genetic variants linked to lower risk for fracture and osteoporosis but higher risk for MI, major CV AEs
Allopurinol Does Not Affect eGFR in Chronic Kidney Disease
And, serum urate lowering with allopurinol did not affect GFR in T1DM and diabetic kidney disease
Tocilizumab Shows Promise for Treatment of COVID-19
Tocilizumab improves oxygenation and inflammatory biomarkers, may improve survival in severe disease
CDC: 10.7 Percent of U.S. Adults Used Rx Pain Meds in 2015 to 2018
No change found in use of prescription opioids from 2009-2010 to 2017-2018, but increase seen in nonopioid meds
Nephrogenic Systemic Fibrosis Rare With Newer GBCA Exposure
Data scant on exposure to gadolinium-based contrast agents for those with acute kidney injury, risk for CKD
Vitamin D May Cut Colitis Risk for Immune Checkpoint Inhibitors
Odds of developing ICI colitis significantly reduced with vitamin D use in patients with melanoma
